Pediatr. praxi. 2011;12(1):12-14

Rotavirus infections in the era of vaccination

MUDr.Pavel Kosina, Ph.D.1, MUDr.Jan Smetana, Ph.D.2, RNDr.Vanda Boštíková, Ph.D.2, MUDr.Jana Krausová1
1 Klinika infekčních nemocí, LF UK a FN v Hradci Králové
2 Katedra epidemiologie, Fakulta vojenského zdravotnictví Univerzity obrany v Hradci Králové

Rotavirus gastroenteritides are among the most common childhood diseases affecting both developed and less developed countries.

The high proportion of hospitalized children, treatment costs, complications and even deaths in countries with a low level of health care

have initiated the efforts to develop a suitable vaccine against this infectious disease. The two currently used oral attenuated vaccines are

being implemented in national immunization programmes in accordance with WHO recommendations. The countries with good-quality

pre-vaccination and vaccination surveillance have an opportunity to observe the economic as well as health impacts of vaccination on

the health of both the paediatric and adult populations. An example of a Central European country is Austria with available data covering

the period of population-wide vaccination. These data can be utilized by other countries lacking such good-quality surveillance. Careful

post-registration monitoring related to the potential minimal risk of increased intussusception continues to be of utmost importance.

Keywords: gastroenteritis, rotaviruses, surveillance, vaccination

Published: February 23, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kosina P, Smetana J, Boštíková V, Krausová J. Rotavirus infections in the era of vaccination. Pediatr. praxi. 2011;12(1):12-14.
Download citation

References

  1. Pazdiora P, Ambrožová H. Rotaviry - nejčastější příčina závažných rotavirových gastroenteritid u dětí. Praha: Grada Publishing, a. s. 2010: 62.
  2. WHO. Weekly Epidemiological Record. 2007; 32(82): 285-296.
  3. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus dinase in children. Emerg Infect Dis 2003? 9: 565-572. Go to original source... Go to PubMed...
  4. Parashar UD, Gibson CJ, Bresse JS, et al. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006; 12: 304-306. Go to original source... Go to PubMed...
  5. Forster J, Guarino A, Parez N, et al. Hospital-Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger Than 5 Years of Age. Pediatrics 2009; 123: 393-400. Go to original source... Go to PubMed...
  6. Pazdiora P. Rotavirové infekce, současné možnosti očkování. Pediatr pro Praxi 2007? 8: 88-91.
  7. Dostál V, et al. Infektologie. Praha: Karolinum? 2004: 338.
  8. Dickey M, Jamison L, Michaud LC, et al. Rotavirus Meningoencephalitis in a Previously Healthy Child and a Review of the Literature. Pediatr Infect Dis J: 2009? 28(4): 318-321. Go to original source... Go to PubMed...
  9. Staňková M, Marešová V, Vaništa J. Repetitorium infekčních nemocí. Praha: Triton? 2008: 207.
  10. Cheuvart B, Friedland LR, Abu-elyazeed R, et al. The Human Rotavirus Vaccine RIX4414 in Infants. A Review of Safety and Tolerability. Ped Inf Dis J: 2009? 28(3): 225-232. Go to original source... Go to PubMed...
  11. Plosker GL. Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe. Drugs 2010; 18, 70(9): 1165-1188. Go to original source... Go to PubMed...
  12. Chlíbek R, Smetana J, Kosina P. Lexikon očkovacích látek dostupných v ČR. Olomouc: Solen, 2010: 122.
  13. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000639/WC500054789.pdf.
  14. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000669/WC500054185.pdf.
  15. Rotavirus vaccines: an update. http://www.who.int/wer/2009/wer8451_52.pdf.
  16. Rendi-Wagner P, Kundi M, Mikolasek A, et al. Active hospital-based surveillance of rotavirus diarrhoea in Austrian children, period 1997-2003. Wien Klin Wochenschr 2006? 118: 280-285. Go to original source... Go to PubMed...
  17. Korinek MP, Rendi-Wagner P, Kundi M, et al. Universal Mass Vaccination Against Rotavirus Gastroenteritis. Ped Inf Dis J 2010; 29(4): 319-323. Go to original source...
  18. FDA. Vaccines, Blood and Biologics. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/AprovedProducts/.
  19. Global Advisory Committee on Vaccine Safety. Statement on Rotarix and Rotateq vaccines and intussusception. September 2010. http://www.who.int/vaccine_safety/topics/rotavirus/rotarix_and_rotateq/intussusception_sep2010/en/index.html.
  20. Cabrnochová H. Změny očkovacího kalendáře. http://www.pmfhk.cz/Prednasky/HVD_2009/2_Cabrnochova.pdf.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.